Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil dose comparison with propofol maintenance anesthesia in elective upper limb orthopedic surgery
IRCT20251228068470N1Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Mar 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of remifentanil and propofol (2 arms), sponsored by Hormozgan University of Medical Sciences. Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 6 more. Started Mar 2026; status: completed.
02
Drugs
remifentanilpropofol
Beyond the preview
Go deeper on IRCT20251228068470N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251228068470N1.